DyrDoktor ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 10.5% 13.7% 23.4% 12.2%  
Credit score (0-100)  0 23 15 3 18  
Credit rating  N/A BB BB B BB  
Credit limit (kDKK)  0.0 0.0 -0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 1,300 125 1,603 -4.7  
EBITDA  0.0 36.4 -1,381 1,346 -4.9  
EBIT  0.0 14.7 -1,427 1,346 -4.9  
Pre-tax profit (PTP)  0.0 6.5 -1,474.0 1,323.0 -9.7  
Net earnings  0.0 3.3 -1,156.9 1,032.0 -7.7  
Pre-tax profit without non-rec. items  0.0 6.5 -1,474 1,323 -9.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 211 165 0.0 0.0  
Shareholders equity total  0.0 43.3 -1,114 -82.0 -89.7  
Interest-bearing liabilities  0.0 277 1,883 438 456  
Balance sheet total (assets)  0.0 1,000 1,033 589 376  

Net Debt  0.0 120 1,797 423 415  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 1,300 125 1,603 -4.7  
Gross profit growth  0.0% 0.0% -90.4% 1,179.2% 0.0%  
Employees  0 2 3 0 0  
Employee growth %  0.0% 0.0% 50.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,000 1,033 589 376  
Balance sheet change%  0.0% 0.0% 3.3% -43.0% -36.1%  
Added value  0.0 36.4 -1,380.6 1,392.6 -4.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 189 -93 -165 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 -1.0 1.0 -1.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 1.1% -1,138.9% 84.0% 104.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 1.5% -90.7% 96.3% 1.5%  
ROI %  0.0% 3.9% -122.5% 114.0% 2.0%  
ROE %  0.0% 7.7% -214.9% 127.2% -1.6%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 4.3% -51.9% -12.2% -19.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 329.6% -130.1% 31.4% -8,494.9%  
Gearing %  0.0% 639.1% -169.1% -534.1% -508.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 6.3% 4.3% 2.9% 4.1%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.5 0.2 0.9 0.8  
Current Ratio  0.0 0.9 0.4 0.9 0.8  
Cash and cash equivalent  0.0 156.8 86.5 15.0 41.2  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -100.7 -1,217.9 -82.0 -89.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 18 -460 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 18 -460 0 0  
EBIT / employee  0 7 -476 0 0  
Net earnings / employee  0 2 -386 0 0